COMMUNIQUÉS West-GlobeNewswire

Theratechnologies fournit une mise à jour quant aux prescriptions et au remboursement de Trogarzo(MC) (ibalizumab-uiyk) injection
16/05/2018
MONTRÉAL, 16 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) a fait part aujourd’hui, lors de l’assemblée annuelle des actionnaires, d’informations relatives au nombre de prescriptions et au remboursement [...]
Announcements In Conjunction With Theratechnologies Annual Meeting
16/05/2018
MONTREAL, May 16, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) today held its annual meeting of shareholders. As part of the meeting, shareholders proceeded to elect the Company’s Board of Directors for a [...]
Annonces en marge de l’assemblée annuelle de Theratechnologies
16/05/2018
MONTRÉAL, 16 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (TSX: TH ) a tenu aujourd’hui son assemblée annuelle des actionnaires. Au cours de l’assemblée, les actionnaires ont élu les membres du conseil d’ [...]
Kommuniké från årsstämman i LIDDS
16/05/2018
Den 16 maj 2018 hölls årsstämma i LIDDS AB (publ). Nedan följer sammanfattning av de beslut som fattades. Beslut fattades med erforderlig majoritet . Vid stämman var 2 418 048 (11,1 %) av totalt 21 871 188 aktier [...]
Medtronic Begins U.S. Study of Drug-Eluting Stents to Evaluate Treatment of Bifurcation Lesions in Patients with Coronary Artery Disease
16/05/2018
Medtronic Received IDE Approval from FDA to Generate Clinical Evidence with Resolute Onyx DES to Support Future Application for Expanded Indication in U.S. DUBLIN - May 16, 2018 - Medtronic plc (NYSE: MDT) today [...]
Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä
16/05/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 16 MAY 2018 at 16.40 EEST Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]
Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä
16/05/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 16 MAY 2018 at 16.30 EEST Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]
Scythian Biosciences Announces ColCanna SAS’ Receipt of Licence to Cultivate and Import CBD into Colombia
16/05/2018
– ENTERS INTO EXCLUSIVE SUPPLY AGREEMENT WITH APHRIA – – COLCANNA TO BE FIRST TO MARKET WITH APHRIA’S PHARMACEUTICAL GRADE CBD OIL IN COLOMBIA – TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the [...]
Innovate Biopharmaceuticals Reports First Quarter 2018 Key Financial and Corporate Highlights
16/05/2018
Further data on larazotide’s mechanism of action, dose response and pharmacology expected at DDW (June 2-5) in Washington D.C. Addition to senior management of June Almenoff, M.D., PhD. as COO and CMO (former principal [...]
Sienna Biopharmaceuticals to Present SNA-125 Pre-Clinical Psoriasis Data as Late-Breaker at the International Investigative Dermatology Congress
16/05/2018
WESTLAKE VILLAGE, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced that pre-clinical data from the Company’s topical product candidate SNA-125, a novel, selective [...]
Crisp Regional Health, Inc. Selects Cerner Integrated EHR to Support Improved Patient Care
16/05/2018
CORDELE, Ga., May 16, 2018 (GLOBE NEWSWIRE) -- Crisp Regional Health, Inc. has selected Cerner, a global leader in health care technology, to implement a new integrated electronic health record (EHR) and revenue cycle [...]
Zealand Pharma - Interim report for the first quarter of 2018
16/05/2018
Company announcement - No. 14 / 2018 Zealand Pharma - Interim report for the first quarter of 2018 Copenhagen, May 16, 2018 - Zealand Pharma A/S ("Zealand") (Company reg. No. 20 04 50 78), the Copenhagen-based company [...]
Oxford Immunotec to Present at the 2018 UBS Global Healthcare Conference
16/05/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 16, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, [...]
Media Advisory: Monday, May 21 - 2018 Diabetes Innovation Challenge Pitch Off
16/05/2018
ROYAL SONESTA BOSTON 3:00 PM – 5:00 PM $250,000 IN CASH AND IN-KIND PRIZES TO BE AWARDED BOSTON, May 16, 2018 (GLOBE NEWSWIRE) -- Ten finalists, all academic researchers and early stage companies, will compete on May 21 [...]
Progyny and Happify Health Give People Dealing with Infertility New Digital Emotional Support Tools
16/05/2018
NEW YORK, May 16, 2018 (GLOBE NEWSWIRE) -- For many people dealing with infertility, the emotional impact may be as challenging as the medical roadblocks. But there are resources that can help. Progyny , the leading [...]
Devonian Health Group Announces Canadian Patent for its Purgenesis™ anti-aging treatment
16/05/2018
QUEBEC CITY, May 16, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSX VENTURE:GSD) today announced that the Canadian Intellectual Property Office issued a Notice of Allowance [...]
Groupe Santé Devonian reçoit l’avis d’acceptation pour le brevet canadien de son traitement anti-âge Purgenesis(MC)
16/05/2018
QUÉBEC, 16 mai 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) annonçait aujourd’hui avoir reçu un avis d’acceptation de l’Office de la propriété intellectuelle [...]
LIDDS signs license agreement for prostate cancer drug Liproca® Depot with major Chinese pharma company
16/05/2018
UPPSALA, SWEDEN - LIDDS AB (publ) has signed a license agreement for Liproca® Depot with Jiangsu Ambition Medical, a Chinese pharmaceutical company specializing in global collaborations and in-licensing. Liproca® Depot [...]
Corcept Therapeutics Announces Presentations at the American Association of Clinical Endocrinologists 27th Annual Congress
16/05/2018
MENLO PARK, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT ), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe [...]

Pages